Primary Site >> Liver Cancer
Gene >> B3GAT1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: [Immunological effects of locoregional immunochemotherapy for liver metastases of gastric cancer]. PMID: 8373205 |
Ref: Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12. PMID: 7722291 |
Ref: Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis. PMID: 8617962 |
Ref: Comparison of intrahepatic lymphocytes from normal and growth hormone transgenic mice with chronic hepatitis and liver cancer. PMID: 9155649 |
Ref: AsGM1+ NK cells prevent metastasis of invading LD-MCA-38 tumor cells in the nude mouse. PMID: 10357913 Ref: Augmentation of local antitumor immunity in the liver by tumor vaccine modified to secrete murine interleukin 12. PMID: 10455415 Ref: Regulatory peptide receptors in human hepatocellular carcinomas. PMID: 10517918 |
Ref: Alpha-glycosylceramides enhance the antitumor cytotoxicity of hepatic lymphocytes obtained from cancer patients by activating CD3-CD56+ NK cells in vitro. PMID: 10903777 Ref: Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver. PMID: 10955826 Ref: Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with the melanoma B16 hepatic metastasis and immunohistological study of tumor infiltrating cells. PMID: 11132924 |
Ref: Liver and circulating NK1.1(+)CD3(-) cells are increased in infection with attenuated Salmonella typhimurium and are associated with reduced tumor in murine liver cancer. PMID: 12384070 |
Ref: Suppression of hepatocellular carcinoma growth via oral immune regulation towards tumor-associated antigens is associated with increased NKT and CD8+ lymphocytes. PMID: 15218301 |
Ref: IFN-producing killer dendritic cells contribute to the inhibitory effect of poly I:C on the progression of murine melanoma. PMID: 18528299 |
Ref: Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage. PMID: 19635861 |
Ref: Induction of tumor-specific acquired immunity against already established tumors by selective stimulation of innate DEC-205(+) dendritic cells. PMID: 20221597 Ref: Prolonged survival of human hepatocarcinoma cells in the liver of newborn C57BL/6 mice and resulting cellular xenorejection, especially the activation of hepatic natural killer T cells. PMID: 20516727 Ref: TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor. PMID: 20977675 |
Ref: Simultaneous detection of T lymphocyte-related antigens (CD4/CD8, CD57, TCRbeta) with nuclei by fluorescence-based immunohistochemistry in paraffin-embedded human lymph node, liver cancer and stomach cancer. PMID: 21791906 |
Ref: Suppression of natural killer cells by sorafenib contributes to prometastatic effects in hepatocellular carcinoma. PMID: 23409093 Ref: Diabetic liver injury from streptozotocin is regulated through the caspase-8 homolog cFLIP involving activation of JNK2 and intrahepatic immunocompetent cells. PMID: 23828575 |
Ref: TRAIL-producing NK cells contribute to liver injury and related fibrogenesis in the context of GNMT deficiency. PMID: 25531568 Ref: Interrelations between hepatic stellate cells and immune system cells in patients with hepatocellular carcinoma. PMID: 26193217 |
Ref: Nano-Pulse Stimulation Ablates Orthotopic Rat Hepatocellular Carcinoma and Induces Innate and Adaptive Memory Immune Mechanisms that Prevent Recurrence. PMID: 29533981 |